Capricorn Fund Managers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Capricorn Fund Managers's PFE Position: Q3 2026 in Review
Capricorn Fund Managers increased its Pfizer (PFE) stake by 553% in Q3 2026, buying an estimated $3.26M and bringing the position to 144,568 shares worth $4.12M. The position accounts for 0.39% of the portfolio, ranked #75.
Capricorn Fund Managers first reported a position in PFE in Q4 2021 and has held it in 12 quarters since. The position peaked at $5.99M in Q3 2024. 1,877 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Capricorn Fund Managers held 144,568 shares of Pfizer worth $4.12M as of Q3 2026.
- Capricorn Fund Managers bought 122,438 Pfizer shares in Q3 2026, an estimated $3.26M.
- Pfizer made up 0.39% of Capricorn Fund Managers's portfolio in Q3 2026, its #75 holding.
- Capricorn Fund Managers first reported a position in Pfizer in Q4 2021 and has held it in 12 quarters since.
- Capricorn Fund Managers's Pfizer position peaked at $5.99M in Q3 2024.
- 1,877 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Capricorn Fund Managers's 13F filing for Q3 2026, filed 3 Nov 2026.